Advertisement
Home Tags Cancer: Misc.

Tag: Cancer: Misc.

June 2016 Briefing – Hematology & Oncology

0
Here are what the editors at HealthDay consider to be the most important developments in Hematology & Oncology for June 2016. This roundup includes...
In 2016

U.S. Cancer Survivors Aging, Battling Other Chronic Disease

0
Likelihood of other chronic conditions will stress health care system in next two decades
The experimental drug midostaurin may reverse organ damage in patients with advanced systemic mastocytosis

Midostaurin Beneficial in Advanced Systemic Mastocytosis

0
Organ damage improved in 60 percent of patients with advanced systemic mastocytosis
Certain cancer immunotherapy drugs may increase risk for rheumatic disease

Cancer Immunotherapy May Induce Arthritis, Sicca Syndrome

0
Findings with ipilimumab (anti-CTLA-4) and/or nivolumab (anti-PD-1) for solid tumors
Family-reported quality of end-of-life care is significantly better for patients with cancer or dementia than for patients with other chronic conditions

End-of-Life Care Received Varies Based on Type of Disease

0
Cancer and dementia patients get more access to palliative care
The use of patient navigators improves cancer screening rates among low-income and ethnic minority patients

Use of Patient Navigators Improves Cancer Screening Rates

0
Navigators particularly helpful for low-income and ethnic minority patients
Three cases of primary clear cell sarcoma of the head and neck have been described in three male patients

Report Describes Primary Clear Cell Sarcoma of Head, Neck

0
Three cases described in males on scalp, face, tongue; all had nested tumors with fibrous septae

American Society of Clinical Oncology, June 3-7

0
The 52nd Annual Meeting of the American Society of Clinical Oncology The annual meeting of the American Society of Clinical Oncology was held...
Daratumumab (Darzalex)

ASCO: Adding Daratumumab Early in Myeloma Treatment Efficacious

0
Response rate doubled for patients with relapsed or refractory multiple myeloma
Three-quarters of young or middle-aged Americans with terminal cancer receive aggressive treatment during the last month of their lives

ASCO: Aggressive Treatment Common in Terminal CA Patients

0
Three in four of young or middle-aged patients get aggressive therapies in last months of lives